Wells Fargo’s Core Scientific CORZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.7M Buy
418,544
+275,065
+192% +$6.48M ﹤0.01% 2131
2026
Q1
$2.15M Sell
143,479
-245,075
-63% -$4.18M ﹤0.01% 3219
2025
Q4
$5.66M Buy
388,554
+129,230
+50% +$2.25M ﹤0.01% 2556
2025
Q3
$4.65M Buy
259,324
+80,290
+45% +$1.18M ﹤0.01% 2642
2025
Q2
$3.06M Buy
179,034
+75,252
+73% +$753K ﹤0.01% 2873
2025
Q1
$751K Buy
103,782
+2,934
+3% +$33.4K ﹤0.01% 3838
2024
Q4
$1.42M Buy
100,848
+29,669
+42% +$438K ﹤0.01% 3454
2024
Q3
$844K Sell
71,179
-88
-0.1% -$912 ﹤0.01% 3654
2024
Q2
$663K Buy
71,267
+61,673
+643% +$315K ﹤0.01% 3736
2024
Q1
$34K Buy
+9,594
New +$33.3K ﹤0.01% 5402

Other funds holding CORZ

Wells Fargo's CORZ Position: Q2 2026 in Review

Wells Fargo increased its Core Scientific (CORZ) stake by 192% in Q2 2026, buying an estimated $6.48M and bringing the position to 418,544 shares worth $10.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2131.

Wells Fargo first reported a position in CORZ in Q1 2024 and has held it in 10 quarters since. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Wells Fargo held 418,544 shares of Core Scientific worth $10.7M as of Q2 2026.
  • Wells Fargo bought 275,065 Core Scientific shares in Q2 2026, an estimated $6.48M.
  • Core Scientific made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #2131 holding.
  • Wells Fargo first reported a position in Core Scientific in Q1 2024 and has held it in 10 quarters since.
  • 412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.